Abstract
The majority of lymphomas originate from B cells at the germinal center stage or beyond. Preferential selection of B cell clones by a limited set of antigens has been suggested to drive lymphoma development. However, little is known about the specificity of the antibodies expressed by lymphoma cells, and the role of antibody-specificity in lymphomagenesis remains elusive. Here, we describe a strategy to characterize the antibody reactivity of human B cells. The approach allows the unbiased characterization of the human antibody repertoire on a single cell level through the generation of recombinant monoclonal antibodies from single primary human B cells of defined origin. This protocol offers a detailed description of the method starting from the flow cytometric isolation of single human B cells, to the RT-PCR-based amplification of the expressed Igh, Igκ, and Igλ chain genes, and Ig gene expression vector cloning for the in vitro production of monoclonal antibodies. The strategy may be used to obtain information on the clonal evolution of B cell lymphomas by single cell Ig gene sequencing and on the antibody reactivity of human lymphoma B cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Tonegawa S (1983) Somatic generation of antibody diversity. Nature 302:575–581
Burnet FM (1972) Auto-immunity and auto-immune disease. Medical and Technical Publishing Co Ltd, Lancaster
Goodnow CC et al (1995) Self-tolerance checkpoints in B lymphocyte development. Adv Immunol 59:279–368
Wardemann H et al (2003) Predominant autoantibody production by early human B cell precursors. Science 301:1374–1377
Tiller T et al (2007) Autoreactivity in human IgG + memory B cells. Immunity 26:205–213
Scheid JF et al (2011) Differential regulation of self-reactivity discriminates between IgG + human circulating memory B cells and bone marrow plasma cells. Proc Natl Acad Sci USA 108:18044–18048
Berek C, Milstein C (1988) The dynamic nature of the antibody repertoire. Immunol Rev 105:5–26
Klein U, Dalla-Favera R (2008) Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol 8:22–33
Muramatsu M et al (2000) Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102:553–563
Rui L et al (2011) Malignant pirates of the immune system. Nat Immunol 12:933–940
Küppers R et al (1999) Cellular origin of human B-cell lymphomas. N Engl J Med 341:1520–1529
Küppers R (2005) Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer 5:251–262
Zenz T et al (2010) From pathogenesis to treatment of chronic lymphocytic leukemia. Nat Rev Cancer 10:37–50
Agathangelidis A et al (2011) Unlocking the secrets of immunoglobulin receptors in mantle cell lymphoma: Implications for the origin and selection of the malignant cells. Semin Cancer Biol 21:299–307
Messmer BT et al (2004) Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med 200:519–525
Hervé M et al (2005) Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity. J Clin Invest 115:1636–1643
Catera R et al (2008) Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation. Mol Med 14:665–674
Hadzidimitriou A et al (2009) Evidence for the significant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukemia. Blood 113:403–411
Bahler DW, Levy R (1992) Clonal evolution of a follicular lymphoma: evidence for antigen selection. Proc Natl Acad Sci USA 89:6770–6774
Hussell T et al (1996) Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue. J Pathol 178:122–127
Burger JA et al (2009) The microenvironment in mature B-cell malignancies: a target for new treatment strategies. Blood 114:3367–3375
Steinitz M et al (1977) EB virus-induced B lymphocyte cell lines producing specific antibody. Nature 269:420–422
Lanzavecchia A, Corti D, Sallusto F (2007) Human monoclonal antibodies by immortalization of memory B cells. Curr Opin Biotechnol 18:523–528
Köhler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495–497
McCafferty J et al (1990) Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348:552–554
Tiller T et al (2008) Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J Immunol Methods 329:112–124
Benckert J et al (2011) The majority of intestinal IgA + and IgG + plasmablasts in the human gut are antigen-specific. J Clin Invest 121:1946–1955
Binder M et al (2011) B-cell receptor epitope recognition correlates with the clinical course of chronic lymphocytic leukemia. Cancer 117:1891–1900
Mouquet H et al (2010) Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation. Nature 467:591–595
Tiller T, Busse CE, Wardemann H (2009) Cloning and expression of murine Ig genes from single B cells. J Immunol Methods 350:183–193
Gu H, Rajewsky K (2004) B cell protocols. Humana Press Inc, New York
Scheid JF et al (2009) A method for identification of HIV gp140 binding memory B cells in human blood. J Immunol Methods 343:65–67
Tsuiji M et al (2006) A checkpoint for autoreactivity in human IgM + memory B cell development. J Exp Med 203:393–400
Smilevska T et al (2008) Immunoglobulin kappa gene repertoire and somatic hypermutation patterns in follicular lymphoma. Blood Cells Mol Dis 41:215–218
Fais F et al (1998) Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 102:1515–1525
Thompsett AR et al (1999) V(H) gene sequences from primary central nervous system lymphomas indicate derivation from highly mutated germinal center B cells with ongoing mutational activity. Blood 94:1738–1746
Montesinos-Rongen M et al (1999) Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment. Am J Pathol 155:2077–2086
Stamatopoulos K et al (1997) Follicular lymphoma immunoglobulin kappa light chains are affected by the antigen selection process, but to a lesser degree than their partner heavy chains. Br J Haematol 96:132–146
Noppe SM et al (1999) The genetic variability of the VH genes in follicular lymphoma: the impact of the hypermutation mechanism. Br J Haematol 107:625–640
Aarts WM et al (2000) Variable heavy chain gene analysis of follicular lymphomas: correlation between heavy chain isotype expression and somatic mutation load. Blood 95:2922–2929
Kabat EA, Wu TT (1991) Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites. J Immunol 147:1709–1719
Hummel M et al (1994) Mantle cell (previously centrocytic) lymphomas express VH genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. Blood 84:403–407
Klein U et al (1998) Somatic hypermutation in normal and transformed human B cells. Immunol Rev 162:261–280
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Wardemann, H., Kofer, J. (2013). Expression Cloning of Human B Cell Immunoglobulins. In: Küppers, R. (eds) Lymphoma. Methods in Molecular Biology, vol 971. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-269-8_5
Download citation
DOI: https://doi.org/10.1007/978-1-62703-269-8_5
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-268-1
Online ISBN: 978-1-62703-269-8
eBook Packages: Springer Protocols